The future of prenatal care
Bello is the first wearable that monitors both maternal and fetal health continuously, safely, and comfortably — so every mother can feel connected to her baby and her care team, between visits.
87% of pregnancy-related deaths in the U.S. were deemed preventable with better care and communication.
Source: CDCThe problem
Between infrequent appointments, mothers and doctors are flying blind — and the signals that matter most often go unnoticed.
Chronic maternal stress raises the risk of preterm birth by 20%.
Small-for-gestational-age risk climbs 14% with chronic stress.
Chronic stress raises the chance of low birth weight by 23%.
Fetal distress, missed early care, and delayed emergency response happen when monitoring only occurs in the clinic.
Unscheduled demand and resource overload lead to avoidable hospital visits — for mothers and providers alike.
Unmonitored nutrition and hydration, blood-pressure fluctuations, and back and pelvic pain go untracked.
The solution
A soft, ergonomic wearable that distributes weight comfortably and monitors both maternal and fetal health — safely and non-invasively.
Passive sensors with no radiation.
Predictive analytics tuned to pregnancy, not generic wellness.
Remote doctor alerts and optional data sharing with your care team.
Multiple sensor types work together for a complete picture.
Fetal acoustic sensorsPressure arrayTemperature sensorPPG sensorMicrofluidic Patches™AI retentionCharging port
Companion app
An anxiety-reducing interface that turns sensor data into simple, reassuring insight — from your baby's weekly progress to your daily heart rate and sleep.
Why Bello
| Feature | Bello | Fetal Dopplers | Smart watches | Hospital monitors (CTG) |
|---|---|---|---|---|
| Continuous fetal monitoring | ✓ | Manual only | — | ✓ |
| Maternal vitals (HR / stress) | ✓ | — | ✓ | ✓ |
| Remote doctor alerts | ✓ | — | — | — |
| Mobility (at-home use) | ✓ | ✓ | ✓ | — |
| AI predictive analytics | ✓ | — | Generic | — |
| Reduced anxiety | ✓ | — | Not pregnancy-specific | Clinical setting |
Who it's for
Women ~20–40 — first-time, working, or high-risk pregnancies. Urban/suburban with busy schedules, and rural areas with limited access. They need reassurance, continuous visibility, and stress reduction.
Urban and rural practices facing staffing shortages and high patient loads. They need fewer unnecessary visits, earlier detection, and data-driven decisions.
Public and private insurers and maternal health risk teams, nationwide. They need cost reduction, early intervention, and scalable remote monitoring.
Business model
640,000 serviceable pregnancies × (band + 9 months of subscription + 3 patch packs) ≈ $400M.
The band
Subscription
Microfluidic patches
TAM
Total addressable market
SAM
Silicon Valley & broader West Coast
SOM
Serviceable obtainable market
Go-to-market
Investing in Bello
Funding takes Bello from prototype through clearance, clinical partnerships, and launch.
Join us in transforming maternal health. Be first to hear about pilots and launch.